Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash from Operations: 2010-2024

Historic Cash from Operations for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $6.0 million.

  • Cryo Cell International's Cash from Operations rose 407.89% to $2.5 million in Q3 2025 from the same period last year, while for Aug 2025 it was $5.2 million, marking a year-over-year increase of 4732.0%. This contributed to the annual value of $6.0 million for FY2024, which is 3261.13% down from last year.
  • According to the latest figures from FY2024, Cryo Cell International's Cash from Operations is $6.0 million, which was down 3261.13% from $8.9 million recorded in FY2023.
  • Cryo Cell International's Cash from Operations' 5-year high stood at $8.9 million during FY2023, with a 5-year trough of $6.0 million in FY2024.
  • Moreover, its 5-year median value for Cash from Operations was $8.5 million (2020), whereas its average is $8.0 million.
  • In the last 5 years, Cryo Cell International's Cash from Operations surged by 3450.06% in 2020 and then plummeted by 3261.13% in 2024.
  • Over the past 5 years, Cryo Cell International's Cash from Operations (Annual) stood at $8.5 million in 2020, then decreased by 6.38% to $7.9 million in 2021, then grew by 8.16% to $8.6 million in 2022, then rose by 4.05% to $8.9 million in 2023, then tumbled by 32.61% to $6.0 million in 2024.
  • Its Cash from Operations was $6.0 million in FY2024, compared to $8.9 million in FY2023 and $8.6 million in FY2022.